☆ 4.7 Letter

Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota

ANNALS OF INTERNAL MEDICINE (2015)

期刊

ANNALS OF INTERNAL MEDICINE

卷 163, 期 6, 页码 487-488

出版社

AMER COLL PHYSICIANS

DOI: 10.7326/L15-5139

关键词

-

类别

Medicine, General & Internal

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Immunology

Management of Severe and Severe/Complicated Clostridoides difficile Infection Using Sequential Fecal Microbiota Transplant by Retention Enema

Abbas Hatim Rupawala, Darrel Gachette, Mena Bakhit, Lanre Jimoh, Colleen R. Kelly

Summary: The study found that serial fecal microbiota transplant may not always be effective in patients with severe or complicated Clostridoides difficile infection unresponsive to standard antibiotic therapy, and may lead to serious adverse events.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?

Krishna Vedala, Philip Sobash, Parth Shah, Gilbert-Roy Kamoga

Summary: Clostridioides difficile infection imposes a significant economic burden in inpatient and rural settings. Fecal Microbiota Transplant, although limited by guidelines and resources, has been shown to save an average of $11,603.49 per patient after the first recurrence of CDI. Our study suggests that utilizing FMT in rural hospitals for recurrent CDI treatment could be economically beneficial.

FRONTIERS IN PUBLIC HEALTH (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers

Andrea Piccioni, Federico Rosa, Federica Manca, Giulia Pignataro, Christian Zanza, Gabriele Savioli, Marcello Covino, Veronica Ojetti, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli

Summary: The composition of the human microbiome plays a crucial role in health, and alterations in the microbiota can lead to Clostridium difficile infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Medicine, General & Internal

Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?

Daniel Popa, Bogdan Neamtu, Manuela Mihalache, Adrian Boicean, Adela Banciu, Daniel Dumitru Banciu, Doru Florian Cornel Moga, Victoria Birlutiu

Summary: Faecal microbiota transplant (FMT) is highly effective for recurrent Clostridioides difficile infection (rCDI) with a cure rate of 85-92%, but its role in primary CDI is still uncertain. This study shows FMT's effectiveness in primary severe CDI and the risk of recurrence is related to the number of CDI episodes. Further research on larger cohorts is needed.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection

Pei-Chang Lee, Tien-En Chang, Yen-Po Wang, Kuei-Chuan Lee, Yi-Tsung Lin, Jen-Jie Chiou, Chi-Wei Huang, Ueng-Cheng Yang, Fen-Yau Li, Hui-Chun Huang, Chun-Ying Wu, Yi-Hsiang Huang, Ming-Chih Hou

Summary: This study aimed to investigate the efficacy of FMT for treating rCDI and its association with microbial changes. The research found that successful FMT was related to treatment outcomes and led to dynamic changes in fecal microbial composition.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Immunology

Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection

Elizabeth S. Aby, Byron P. Vaughn, Eva A. Enns, Radha Rajasingham

Summary: This study assessed the cost-effectiveness of fecal microbiota transplantation (FMT) for first recurrent Clostridioides difficile infection (CDI). The findings indicate that FMT is a cost-effective treatment strategy for first recurrent CDI.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Current Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children

Maribeth R. Nicholson, Suchitra K. Hourigan, Maire Conrad, Alka Goyal, Kyle Jensen, Judith Kelsen, Melissa Kennedy, Madison Weatherly, Stacy A. Kahn

Summary: The impact of the 2019 US FDA safety alert and the COVID-19 pandemic on the use of FMT in children has led to changes in practices for many pediatric gastroenterologists, with a majority of programs being halted as a result.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation

Mao Hagihara, Tadashi Ariyoshi, Yasutoshi Kuroki, Shuhei Eguchi, Seiya Higashi, Takeshi Mori, Tsunemasa Nonogaki, Kenta Iwasaki, Makoto Yamashita, Nobuhiro Asai, Yusuke Koizumi, Kentaro Oka, Motomichi Takahashi, Yuka Yamagishi, Hiroshige Mikamo

Summary: CBM 588 enhances the antibacterial activity against C. difficile, reduces colon epithelial damage, and improves immunity through upregulating pathogen specific immunoglobulin A and enhancing gut epithelial barrier function to protect colon tissue from CDI.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Fecal Microbiota Transplantation in Patients Co-Infected with SARS-CoV2 and Clostridioides difficile

Adrian Boicean, Bogdan Neamtu, Sabrina Birsan, Florina Batar, Ciprian Tanasescu, Horatiu Dura, Mihai Dan Roman, Adrian Hasegan, Dan Bratu, Alin Mihetiu, Calin Ilie Mohor, Cosmin Mohor, Ciprian Bacila, Mihai Octavian Negrea, Sorin Radu Fleaca

Summary: In this comparative study on 86 patients with co-infection of COVID-19 and Clostridioides Difficile, fecal microbiota transplantation (FMT) showed better results in terms of inflammatory markers, relapse rate, and symptom relief compared to antibiotic treatment alone. Therefore, FMT may be an effective treatment for improving patients' quality of life and inflammatory syndrome.

BIOMEDICINES (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch, Ilan Youngster, Guy Ben-Betzalel, Rona Ortenberg, Adi Lahat, Lior Katz, Katerina Adler, Daniela Dick-Necula, Stephen Raskin, Naamah Bloch, Daniil Rotin, Liat Anafi, Camila Avivi, Jenny Melnichenko, Yael Steinberg-Silman, Ronac Mamtani, Hagit Harati, Nethanel Asher, Ronnie Shapira-Frommer, Tal Brosh-Nissimov, Yael Eshet, Shira Ben-Simon, Oren Ziv, Md Abdul Wadud Khan, Moran Amit, Nadim J. Ajami, Iris Barshack, Jacob Schachter, Jennifer A. Wargo, Omry Koren, Gal Markel, Ben Boursi

Summary: This study conducted a phase 1 clinical trial and found that FMT treatment in patients with anti-PD-1-refractory metastatic melanoma, along with reinduction of anti-PD-1 immunotherapy, resulted in clinical responses in some patients. This suggests that modulating the gut microbiota could be a promising approach in cancer treatment.

SCIENCE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis

Yao-Wen Cheng, Dana Alhaffar, Srishti Saha, Sahil Khanna, Matthew Bohm, Emmalee Phelps, Marwan Ghabril, Eric Orman, Sagi Sashidhar, Nicholas Rogers, Huiping Xu, Alexander Khoruts, Byron Vaughn, Dina Kao, Karen Wong, Giovanni Cammarota, Gianluca Ianiro, Tanvi Dhere, Colleen S. Kraft, Nirja Mehta, Michael H. Woodworth, Jessica R. Allegretti, Lotem Nativ, Jenna Marcus, Najwa El-Nachef, Monika Fischer

Summary: The study found that FMT was safe and effective in treating CDI in patients with cirrhosis, with a success rate of 85.7%. Risk factors for FMT failure in these patients included the use of non-CDI antibiotics, severe Child-Pugh scores, and probiotic use. The rate of FMT-related adverse events was 33.3%, but severe adverse events were rare and not associated with infection or death.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection

Olle Bjorkqvist, Ignacio Rangel, Lena Serrander, Cecilia Magnusson, Jonas Halfvarson, Torbjorn Noren, Malin Bergman-Jungestrom

Summary: The study found that FMT can increase the relative abundance of Faecalibacterium prausnitzii in patients with recurrent CDI, and this microbial shift persists for several months later. Further research is needed to determine whether Faecalibacterium prausnitzii actively contributes to the resolution of CDI.

PLOS ONE (2021)

添加到收藏夹

Article Microbiology

Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection

Craig Haifer, Sudarshan Paramsothy, Thomas J. Borody, Annabel Clancy, Rupert W. Leong, Nadeem O. Kaakoush

Summary: Oral lyophilized fecal microbiota transplantation (FMT) is effective in treating Clostridioides difficile infection (CDI), improving microbial diversity and resulting in durable engraftment up to 6 months post-treatment, with better efficacy observed in primary CDI compared to recurrent cases. Changes in bacterial and fungal communities are associated with therapy outcomes.

MSYSTEMS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection

Byron P. Vaughn, Monika Fischer, Colleen R. Kelly, Jessica R. Allegretti, Carolyn Graiziger, Juana Thomas, Emma McClure, Amanda J. Kabage, Alexander Khoruts

Summary: This study aimed to evaluate the safety and effectiveness of capsule FMT (cap-FMT) and colonoscopy FMT (colo-FMT) for multiply recurrent Clostridioides difficile infections (rCDIs). The results showed that cap-FMT has a similar safety and effectiveness profile compared with colo-FMT, without the procedural risks of colonoscopy.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Predictors of Fecal Microbiota Transplant Failure in Clostridioides difficile Infection An Updated Meta-analysis

Azizullah Beran, Sachit Sharma, Sami Ghazaleh, Wade Lee-Smith, Muhammad Aziz, Faisal Kamal, Ashu Acharya, Douglas G. Adler

Summary: This meta-analysis explored the predictors of fecal microbiota transplantation (FMT) failure in patients with recurrent/refractory Clostridioides difficile infection (CDI). The study included 20 studies with a total of 4327 patients and found that FMT failed in 16.3% of the patients. Advanced age, severe CDI, inflammatory bowel disease, peri-FMT use of non-CDI antibiotics, prior CDI-related hospitalizations, inpatient status, and poor quality of bowel preparation were significant predictors of FMT failure.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2023)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Evaluating microbial determinants of donor efficacy to translate faecal microbiota transplantation from research to clinical practice

Qin Liu, Giovanni Cammarota, Gianluca Ianiro

GUT (2023)

添加到收藏夹

Letter Gastroenterology & Hepatology

Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease

Francesco Santopaolo, Francesca Romana Ponziani, Andrea Contegiacomo, Maurizio Pompili, Antonio Gasbarrini, Alberto Larghi Gemelli

DIGESTIVE AND LIVER DISEASE (2023)

添加到收藏夹

Letter Gastroenterology & Hepatology

From coagulation imbalance to prediction of advanced chronic liver disease decompensation: The wind of change?

Francesca Romana Ponziani, Francesco Santopaolo, Antonio Gasbarrini, Raimondo De Cristofaro, Maurizio Pompili

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Review Oncology

Increasing the accuracy of colorectal cancer screening

Silvia Pecere, Cristina Ciuffini, Michele Francesco Chiappetta, Lucio Petruzziello, Luigi Giovanni Papparella, Cristiano Spada, Antonio Gasbarrini, Federico Barbaro

Summary: Colorectal cancer is a significant health issue, responsible for nearly 10% of cancer-related deaths. Screening is crucial for early detection of preneoplastic lesions or early-stage cancer. This review summarizes existing screening tools, their pros and cons, and highlights the potential game-changing technologies currently being investigated.

EXPERT REVIEW OF ANTICANCER THERAPY (2023)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study

Lucrezia Laterza, Marco Napoli, Valentina Petito, Franco Scaldaferri, Eleonora Gaetani, Antonio Gasbarrini

Summary: This study evaluated the adherence to probiotic therapy in real-life and identified factors that influenced adherence. It found that 60% of patients took all the prescribed probiotic therapy and perceived benefits in more than 60% of cases. The main factors affecting adherence were the price of the product, mild adverse events, and poor appreciation of flavor.

MINERVA MEDICA (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience

Federica Borrelli de Andreis, Ivo Boskoski, Pietro Mascagni, Tommaso Schepis, Antonio Bianchi, Giovanni Schinzari, Brigida Eleonora Annicchiarico, Giuseppe Quero, Giampaolo Tortora, Sergio Alfieri, Antonio Gasbarrini, Guido Costamagna, Cristiano Spada, Fabia Attili

Summary: This retrospective study evaluated the feasibility and safety of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for unresectable pancreatic insulinomas. The study found that EUS-RFA was technically successful and achieved clinical remission in all patients, with no major complications observed. Complete radiologic response and symptom remission were assessed in all patients during follow-up.

PANCREATOLOGY (2023)

添加到收藏夹

Review Nutrition & Dietetics

Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties

Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani

Summary: The gut microbiota plays a critical role in host metabolism and immune response regulation, and its impairment is associated with various gastrointestinal and extraintestinal diseases. A. muciniphila is proven to be important in maintaining intestinal barrier integrity, modulating the host immune response, and improving metabolic pathways, making it a key factor in the pathogenesis of several human diseases. Further research is needed to explore its mechanisms of action and properties in order to develop a more integrated and personalized therapeutic approach based on the knowledge of gut microbiota.

NUTRIENTS (2023)

添加到收藏夹

Article Immunology

Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy

Rossella Cianci, Laura Franza, Giulia Pignataro, Maria Grazia Massaro, Pierluigi Rio, Antonio Tota, Francesca Ocarino, Marta Sacco Fernandez, Francesco Franceschi, Antonio Gasbarrini, Giovanni Gambassi, Marcello Candelli

Summary: The impact of SARS-CoV-2 vaccination on the prognosis of infected patients was evaluated in this study. Results showed that vaccination with at least two doses reduced the need for ICU admission, and even one shot of the vaccine significantly reduced 30-day mortality. All-cause mortality related to SARS-CoV-2 infection has declined from the first wave to subsequent waves.

VACCINES (2023)

添加到收藏夹

Article Medicine, General & Internal

Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease

Matteo Garcovich, Mattia Paratore, Laura Riccardi, Maria Assunta Zocco, Maria Elena Ainora, Geltrude Mingrone, Antonio Gasbarrini, Maurizio Pompili

Summary: This study aimed to investigate the feasibility, correlation, and accuracy of a new point shear-wave elastography device (X+pSWE) in patients with chronic liver disease. The results showed a good correlation between X+pSWE and 2D-SWE with SSI, with X+pSWE values being slightly lower. X+pSWE had high AUROC values for staging fibrosis, and correctly identified most patients according to histologic classification.

DIAGNOSTICS (2023)

添加到收藏夹

Review Biology

Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis

Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili

Summary: Liver cirrhosis is a chronic disease that often leads to complications such as variceal bleeding, hepatic encephalopathy, ascites, and jaundice, with increased mortality. Infections, particularly spontaneous bacterial peritonitis (SBP), are common in cirrhotic patients due to impaired immunity and altered intestinal microbiota. SBP is primarily caused by Gram-negative bacteria translocating through the defective intestinal barrier. The first-line treatment is antibiotic therapy, but it may worsen dysbiosis. Future therapies aim to selectively modulate the gut microbiota or reduce intestinal permeability.

LIFE-BASEL (2023)

添加到收藏夹

Editorial Material Medicine, Research & Experimental

Clinical research coordinators: Key components of an efficient clinical trial unit

Vincenzina Mora, Stefania Colantuono, Caterina Fanali, Alessia Leonetti, Giulia Wlderk, Maria Antonia Pirro, Francesca Maria Cala Palmarino, Roberta Savini, Gianluca Ianiro, Antonio Gasbarrini

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2023)

添加到收藏夹

Article Medicine, General & Internal

Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves

Luca Miele, Marianxhela Dajko, Maria Chiara D. Savino, Nicola Capocchiano, Valentino Calvez, Antonio Liguori, Carlotta Masciocchi, Lorenzo Vetrone, Irene Mignini, Tommaso Schepis, Giuseppe Marrone, Marco Biolato, Alfredo Cesario, Stefano Patarnello, Andrea Damiani, Antonio Grieco, Vincenzo Valentini, Antonio Gasbarrini, Gemelli COVID Grp

Summary: This study aimed to develop and validate predictive mortality models using data from hospitalized COVID-19 patients. Increased FIB-4 index values were found to be associated with poor clinical outcomes. The study utilized artificial intelligence and big data processing to retrieve data and developed a multivariable logistic regression model. Among 4936 patients, 15.4% died.

INTERNAL AND EMERGENCY MEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

ANCOC Score to Predict Mortality in Different SARS-CoV-2 Variants and Vaccination Status

Marcello Candelli, Marta Sacco Fernandez, Giulia Pignataro, Giuseppe Merra, Gianluca Tullo, Alessandra Bronzino, Andrea Piccioni, Veronica Ojetti, Antonio Gasbarrini, Francesco Franceschi

Summary: Our study aimed to validate the ANCOC score and assess its ability to predict 60-day mortality risk regardless of vaccination status and viral variant. The results suggest that the ANCOC score is able to accurately predict 60-day mortality risk independent of viral variant and vaccination status.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index

Lorenzo Falsetti, Vincenzo Zaccone, Luca Santoro, Silvia Santini, Emanuele Guerrieri, Luca Giuliani, Giovanna Viticchi, Serena Cataldi, Antonio Gasbarrini, Francesco Landi, Angelo Santoliquido, Gianluca Moroncini

Summary: Patients with post-COVID-19 syndrome exhibit greater clinical complexity and a higher burden of comorbidities, as indicated by a higher CCI. Additionally, a higher CCI is associated with an increased risk of post-COVID-19 syndrome, with the presence of 1 or 4 or more CCI points associated with a 3-fold and 6-fold increased risk, respectively.

MEDICINA-LITHUANIA (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression

Osman Oecal, Christoph J. Zech, Matthias P. Fabritius, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Bernhard Gebauer, Thomas Berg, Christian Sengel, Irene Bargellini, Roberto Iezzi, Alberto Benito, Maciej Pech, Antonio Gasbarrini, Bruno Sangro, Peter Malfertheiner, Jens Ricke, Max Seidensticker

Summary: This study aims to identify clinical and imaging parameters associated with the progression of non-hypervascular hepatobiliary phase hypointense lesions during follow-up after treatment for hepatocellular carcinoma. The results suggest that T2 hyperintensity, diffusion restriction, cirrhosis, and higher ECOG-PS are independent risk factors for the progression of these lesions.

EUROPEAN RADIOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.